Navellier & Associates Inc Clear Point Neuro, Inc. Transaction History
Navellier & Associates Inc
- $915 Million
- Q3 2025
A detailed history of Navellier & Associates Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Navellier & Associates Inc holds 50,000 shares of CLPT stock, worth $774,500. This represents 0.12% of its overall portfolio holdings.
Number of Shares
50,000
Previous 50,000
-0.0%
Holding current value
$774,500
Previous $597,000
82.41%
% of portfolio
0.12%
Previous 0.08%
Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
113Shares Held
8.38MCall Options Held
437KPut Options Held
199K-
Vanguard Group Inc Valley Forge, PA1.5MShares$23.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA656KShares$10.2 Million0.0% of portfolio
-
State Street Corp Boston, MA483KShares$7.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.68 Million0.0% of portfolio
-
Ubs Group Ag361KShares$5.59 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $379M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...